A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Addressing Disparities in Breast Cancer Care: An Approach to Health Equity
1 other identifier
interventional
126
1 country
1
Brief Summary
This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedStudy Start
First participant enrolled
December 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 15, 2028
February 17, 2026
February 1, 2026
3.2 years
April 1, 2024
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Enrollment rate
Enrollment rate Will be defined as the number of patients enrolled divided by the number of patients approached. The enrollment rate will be estimated with a 90% credible region obtained by Jeffrey's prior method.
Up to 2 years
Reasons for refusal
Reported reasons of refusal will be summarized using frequencies and relative frequencies
Up to 2 years
Retention Rate
The number of patients that complete patient navigation divided by the number of patients enrolled
Up to 2 years
Reasons for discontinuation
Will be summarized using frequencies and relative frequencies
Up to 2 years
Secondary Outcomes (5)
European Organization for Research and Treatment of Cancer Quality of Life Scale (EORTC QLQ-C30)
Up to 2 years
Social Determinates of health
Up to 2 years
Barriers to care
Up to 2 years
Use of supportive services
Up to 2 years
Patient Satisfaction survey
up to 2 years
Study Arms (1)
Health Services Research (Patient Navigation)
EXPERIMENTALPatients receive patient navigation services from a patient navigator as needed to improve knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance skills related to management of cancer treatment
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years of age
- Have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
- Currently identify their gender as woman or female
- Was assigned female sex at birth (AFAB)
- \- Participant is experiencing ≥1 barrier to care as determined by the social needs screening tool
- Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention
You may not qualify if:
- Participants who are not suspected of or diagnosed with breast cancer or Ductal Carcinoma in Situ (DCIS)
- Participants who have had a previous diagnosis of any cancer
- Participants who were assigned male sex or intersex at birth
- Unwilling or unable to follow protocol requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathryn Glaser
Roswell Park Comprehensive Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2024
First Posted
April 5, 2024
Study Start
December 15, 2024
Primary Completion (Estimated)
March 15, 2028
Study Completion (Estimated)
March 15, 2028
Last Updated
February 17, 2026
Record last verified: 2026-02